Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LBX Pharmacy Chain JSC (SHSE:603883) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
LBX Pharmacy Chain JSC Forward PE Ratio Related Terms
LBX Pharmacy Chain JSC Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for LBX Pharmacy Chain JSC's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LBX Pharmacy Chain JSC Forward PE Ratio Chart
LBX Pharmacy Chain JSC Annual Data
Trend
2024-12
2025-12
Forward PE Ratio
12.07
15.30
LBX Pharmacy Chain JSC Quarterly Data
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
Forward PE Ratio
12.07
13.09
17.96
13.77
15.30
13.66
LBX Pharmacy Chain JSC Forward PE Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, LBX Pharmacy Chain JSC's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LBX Pharmacy Chain JSC Forward PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LBX Pharmacy Chain JSC's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where LBX Pharmacy Chain JSC's Forward PE Ratio falls into.
LBX Pharmacy Chain JSC Forward PE Ratio Calculation
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
LBX Pharmacy Chain JSC (SHSE:603883) has a Forward PE Ratio of 15.46 as of Aug. 26, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on LBX Pharmacy Chain JSC and its competitors. According to the industry distribution chart, LBX Pharmacy Chain JSC ranks #115 out of 316 companies in the Healthcare Providers & Services industry, placing it in the top 36.4%.
Is LBX Pharmacy Chain JSC's Forward PE Ratio too high?
LBX Pharmacy Chain JSC's current Forward PE Ratio is 15.46. The Healthcare Providers & Services industry median Forward PE Ratio is 19.25. LBX Pharmacy Chain JSC's value of 15.46 is 19.7% below this industry median. Based on the distribution chart, LBX Pharmacy Chain JSC ranks #115 out of 316 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, LBX Pharmacy Chain JSC has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LBX Pharmacy Chain JSC's Forward PE Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, LBX Pharmacy Chain JSC ranks #115 out of 316 companies for Forward PE Ratio. This puts LBX Pharmacy Chain JSC in the upper half of its industry. The industry median Forward PE Ratio is 19.25. LBX Pharmacy Chain JSC's value of 15.46 is 19.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Healthcare Providers & Services company?
The median Forward PE Ratio among Healthcare Providers & Services companies is 19.25, based on 316 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LBX Pharmacy Chain JSC's current Forward PE Ratio of 15.46 is 19.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on LBX Pharmacy Chain JSC and its competitors. For the Healthcare Providers & Services industry, the median Forward PE Ratio is 19.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LBX Pharmacy Chain JSC's current Forward PE Ratio is 15.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LBX Pharmacy Chain JSC stock overvalued right now?
Based on GuruFocus' analysis, LBX Pharmacy Chain JSC (SHSE:603883) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥19.42, compared to a current price of ¥13.04 — trading 32.9% below its estimated fair value. The current Forward PE Ratio is 15.46 and 19.7% below the Healthcare Providers & Services industry median of 19.25. LBX Pharmacy Chain JSC's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For LBX Pharmacy Chain JSC (SHSE:603883), the current Forward PE Ratio is 15.46 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LBX Pharmacy Chain JSC (SHSE:603883) Overvalued in 2026?
Based on GuruFocus' analysis, LBX Pharmacy Chain JSC stock appears to be undervalued.
The current stock price of ¥13.04 is trading 32.9% below its estimated GF Value™ of ¥19.42.
GuruFocus considers LBX Pharmacy Chain JSC to be Significantly Undervalued.
Key valuation signals for SHSE:603883:
Forward PE Ratio: 15.46
GF Value™: ¥19.42 vs. price of ¥13.04 (32.9% below fair value)
Industry Position: 19.7% below the Healthcare Providers & Services median (#115 of 316)
No single metric tells the full story. See the SHSE:603883 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LBX Pharmacy Chain JSC is a China-based company engages in the sale of medicine and health products. The company is engaged in retailing drugs and other related products, including Chinese and Western medicine, prepared slices of Chinese crude drugs, health equipment, healthy food, and personal care products and life care products. The company is also involved in the wholesale and manufacture of drugs.
83GF Score
Get the complete analysis for SHSE:603883
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603883 has been successfully added to your 
